Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-04-27 @ 2:33 PM
Study NCT ID:
NCT05898620
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
Sponsor:
Neurogene Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RTT-200
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None